MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2023

Jul 2, 2023

==> picture [116 x 29] intentionally omitted <==

ASX Announcement

03 July 2023

MACH7 TO PARTICIPATE IN VETERANS HEALTH ADMINISTRATION’S NEXTGEN PACS[1] PROGRAM

• Mach7 to provide VNA[2] , eUnity, and Professional Services to VHA’s National Teleradiology Program

• Phase I potential TCV[3] of A$11.7M[4] ; potential to increase to A$59.6M with Phase II

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions, is pleased to announce its participation in the Veterans Health Administration’s (VHA’s) National Teleradiology Program (NTP). As part of the contract, Mach7 will provide its VNA and eUnity Enterprise Diagnostic Viewer solutions which will help form the core of the NTP NextGen PACS architecture.

The VHA NTP is Veterans Affairs’ in-house teleradiology service which has been providing 24x7 service to VHA facilities for over a decade. The NTP currently supports 125 sites across all 18 Veterans Integrated Services Networks (VISNs) and is projected to interpret between 1.0 and 1.5 million studies annually.

The NTP seeks a best of breed, next generation PACS (“NextGen PACS”) that is designed, deployed, and optimised for its teleradiology workflow and reading environment. The system will also serve as a replacement PACS for VISNs as they transition off existing contracts.

The NextGen PACS program involves two major phases. Phase I will see Mach7’s VNA and eUnity viewer solutions form the core of NTP’s NextGen PACS. This phase has a potential TCV of A$11.7 million with a 12 month implementation/Professional Service fee period then a fee per study subscription license over a three year term. Phase II, which is contingent upon a number of success factors in Phase I, involves expansion into Veterans Affairs’ hospital network to support up to seven VISNs with migration, integration and software representing additional potential TCV of A$47.9 million over a five year term.

Mach7’s participation in the project is as one of several subcontractors to the prime vendor, Frontier Acquisitions, LLC

Mach7’s Chief Executive Officer, Mike Lampron, said: “As a veteran myself, I’m proud that Mach7 has been given the honour to do its part in supporting our veterans. Beyond the incredible privilege to serve this very special part of our community, this opportunity will allow us to expand our footprint into the US public

1 Picture Archiving and Communication System

2 Vendor Neutral Archive

3 Total Contract Value

4 Exchange rate: AUD/USD = $0.6627; All values expressed in Australian dollars unless otherwise stated

health sector. I look forward to working with Frontier and other vendors to build a market leading, nextgeneration PACS that will help provide essential care and services to our Veterans.”

Released on authority of the Board by:

Mike Lampron

Managing Director and Chief Executive Officer

For more information, contact:

Rebecca Thompson Head of Investor Relations Mach7 Technologies Limited +61 (0) 416 079 329 Rebecca.Thompson@mach7t.com

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing enterprise Data Management, Enterprise Diagnostic Viewing and Diagnostic Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Diagnostic Workflow applications. eUnity is a zero-footprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

==> picture [206 x 73] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222

www.mach7t.com